- Home
- ADTX vs ADIL Comparison
ADTX vs ADIL Comparison
Compare ADTX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- ADIL
- Stock Information
- Founded
- ADTX 2017
- ADIL 2010
- Country
- ADTX United States
- ADIL United States
- Employees
- ADTX N/A
- ADIL N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- ADIL Health Care
- Exchange
- ADTX Nasdaq
- ADIL Nasdaq
- Market Cap
- ADTX 5.3M
- ADIL 4.3M
- IPO Year
- ADTX 2020
- ADIL 2018
- Fundamental
- Price
- ADTX $5.00
- ADIL $0.69
- Analyst Decision
- ADTX
- ADIL Strong Buy
- Analyst Count
- ADTX 0
- ADIL 1
- Target Price
- ADTX N/A
- ADIL $8.00
- AVG Volume (30 Days)
- ADTX 8.1M
- ADIL 73.2K
- Earning Date
- ADTX 05-19-2025
- ADIL 05-13-2025
- Dividend Yield
- ADTX N/A
- ADIL N/A
- EPS Growth
- ADTX N/A
- ADIL N/A
- EPS
- ADTX N/A
- ADIL N/A
- Revenue
- ADTX $133,985.00
- ADIL N/A
- Revenue This Year
- ADTX $95.61
- ADIL N/A
- Revenue Next Year
- ADTX $1,584.79
- ADIL N/A
- P/E Ratio
- ADTX N/A
- ADIL N/A
- Revenue Growth
- ADTX N/A
- ADIL N/A
- 52 Week Low
- ADTX $4.11
- ADIL $0.61
- 52 Week High
- ADTX $35,000.00
- ADIL $3.10
- Technical
- Relative Strength Index (RSI)
- ADTX 33.28
- ADIL 45.87
- Support Level
- ADTX $4.17
- ADIL $0.67
- Resistance Level
- ADTX $7.69
- ADIL $0.74
- Average True Range (ATR)
- ADTX 1.92
- ADIL 0.05
- MACD
- ADTX 0.36
- ADIL 0.00
- Stochastic Oscillator
- ADTX 10.10
- ADIL 58.33
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.